Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Nithya Ramnath"'
Autor:
Alex K. Bryant, Kamya Sankar, Lili Zhao, Garth W. Strohbehn, David Elliott, Drew Moghanaki, Michael J. Kelley, Nithya Ramnath, Michael D. Green
Publikováno v:
European Journal of Cancer. 171:55-63
One year of adjuvant durvalumab following concurrent chemoradiotherapy significantly improves progression-free survival (PFS) and overall survival (OS) for patients with stage III non-small cell lung cancer (NSCLC). However, the optimal length of adj
Autor:
Jason W.D. Hearn, Philip S. Boonstra, Matthew J. Schipper, Theodore S. Lawrence, James A. Hayman, Gregory P. Kalemkerian, Randall K. Ten Haken, Paul Stanton, Nithya Ramnath, S. Hobson, Feng-Ming Spring Kong, Martha M. Matuszak, Shruti Jolly, Peter G. Hawkins
Publikováno v:
Radiotherapy and Oncology. 125:66-72
Background and purpose Current methods to estimate risk of radiation-induced lung toxicity (RILT) rely on dosimetric parameters. We aimed to improve prognostication by incorporating clinical and cytokine data, and to investigate how these factors may
Autor:
Dafydd G. Thomas, Bruce W. Hollis, Guoan Chen, Amanda N. King, So Hee Kim, Nithya Ramnath, Dean E. Brenner, Paul J. Christensen, David G. Beer, Lili Zhao, Robert U. Simpson, Chae Kyung Jeon, Thomas J. Giordano
Publikováno v:
Lung Cancer. 77:265-271
Purpose The anti-proliferative effects of 1α,25-dihydroxyvitamin D 3 (1,25-D 3 , calcitriol, the active form of vitamin D) are mediated by the nuclear vitamin D receptor (VDR). In the present study, we characterized VDR expression in lung adenocarci
Autor:
Antoinette J. Wozniak, Bryan J. Schneider, Nithya Ramnath, Shirish M. Gadgeel, John C. Ruckdeschel, Francis P. Worden, Wei Chen, Xiaohui Zhang, Gregory P. Kalemkerian, Michael J. Kraut
Publikováno v:
Clinical Lung Cancer. 11:223-227
Background The prognosis for patients with extensive-stage small-cell lung cancer remains poor. This trial was designed to evaluate irinotecan/cisplatin plus maintenance imatinib in patients with c-Kit–positive disease (the transmembrane receptor c
Autor:
Alex A. Adjei, Nithya Ramnath
Publikováno v:
Update on Cancer Therapeutics. 2:111-118
The RAS/RAF/MEK/ERK signaling pathway plays a central role in the regulation of many cellular processes including proliferation, survival, differentiation, apoptosis, motility and metabolism. This pathway is activated by a diverse group of extracellu
Autor:
Fengzhi Li, Jie Yang, Xiang Ling, Dong Feng Tan, Harry K. Slocum, Muxiang Zhou, Brian N. Bundy, Nithya Ramnath, Tallal Younis, Li Ly Yang
Publikováno v:
Lung Cancer. 49:353-361
Although it was observed that inhibition of the antiapoptotic protein survivin expression in lung cancer cells induces apoptosis, the expression and role of survivin variants (survivin-2B and survivin-DeltaEx3) in lung cancer have not yet been charac
Autor:
Ramaswamy Govindan, Nithya Ramnath
Publikováno v:
Clinical Lung Cancer. 10:260-261
Autor:
Geroid Bepler, Eric Sommers, Jeannie Vaughn, Eric B. Haura, Carol Sherer, Chume Nwogu, Timothy M. Anderson, Nithya Ramnath, Lary A. Robinson, Caio Max S. Rocha Lima
Publikováno v:
Lung Cancer. 41:S283-S284
Autor:
Alan B. Cantor, Alberto Chiappori, Lary A. Robinson, Chukwumere Nwogu, Anupama Sharma, Dongfeng Tan, Charles Williams, Gerold Bepler, Eric Sommers, Nithya Ramnath
Publikováno v:
Lung Cancer. 49:S96
Publikováno v:
Lung Cancer. 49:S21